Results 101 to 110 of about 280 (113)

A 12-week treatment with fractional CO2laser for vulvovaginal atrophy: a pilot study

Climacteric, 2014
S Salvatore, Rossella E Nappi, Nicola Zerbinati   +2 more
exaly  

Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis

American Journal of Obstetrics and Gynecology, 1985
Jack D Sobel
exaly  

Vulvovaginal candidiasis: Epidemiologic, diagnostic, and therapeutic considerations

American Journal of Obstetrics and Gynecology, 1998
Jack D Sobel, Rex W Force, Betsy Foxman
exaly  

Psychosexual aspects of vulvovaginal pain

Best Practice and Research in Clinical Obstetrics and Gynaecology, 2014
Sophie Bergeron, Marc Steben
exaly  

Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India

European Journal of Obstetrics, Gynecology and Reproductive Biology, 2009
Anis Ahmad, Asad U Khan
exaly  

Sexual function after fractional microablative CO2laser in women with vulvovaginal atrophy

Climacteric, 2015
S Salvatore, Rossella E Nappi, M Parma
exaly  

Vulvovaginal examinations in elderly nursing home women residents

Archives of Gerontology and Geriatrics, 2000
Arthur Leibovitz, Beni Habot
exaly  

Comprehensive management of vulvovaginal cancers

Ca-A Cancer Journal for Clinicians
Angelica Nogueira-Rodrigues, Maaike H M Oonk, Domenica Lorusso   +2 more
exaly  

Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species

Expert Opinion on Pharmacotherapy, 2018
Jack D Sobel
exaly  

Vulvovaginal Atrophy

Mayo Clinic Proceedings, 2010
Deborah J Rhodes, Lynne T Shuster
exaly